Bildyos is supplied as a 60mg/mL single-dose prefilled syringe and single-dose vial; Bilprevda is supplied as a 120mg/1.7mL single-dose vial. Bilprevda is indicated to prevent skeletal-related events ...

Boncresa is supplied as a 60 mg/mL single-dose prefilled syringe for SC injection and Oziltus is supplied as a 120 mg/1.7 mL single-dose vial for SC injection. Boncresa is approved to treat ...

The FDA has approved two new drugs that are biosimilars to denosumab, adding to the ever-expanding field of less expensive options of the popular anti-osteoporosis and cancer-related bone loss drug; ...

The Food and Drug Administration (FDA) has approved Osvyrti ® (denosumab-desu), a biosimilar to Prolia ® (denosumab), and Jubereq ® (denosumab-desu), a biosimilar to Xgeva ® (denosumab). Osvyrti is ...

Denosumab is a monoclonal antibody that inhibits bone resorption and is widely used across oncology and osteoporosis-related conditions. The Patels added, "With the addition of two denosumab ...